Endothelix, Inc. is a cardiovascular device company based in Houston, Texas and is focused on non-invasive vascular function measurement. The company originated from the Texas Medical Center-Houston from a collaborative project between the Texas Heart Institute and The University of Texas Health Science Center at Houston. Endothelix received a $1 million award from the Texas Emerging Technology Fund to develop the VENDYS® technology. Endothelix’s first product is VENDYS®, a non-invasive, inexpensive, and easy to use vascular function test. VENDYS® is FDA approved and is currently marketed throughout the United States, Europe and Canada. The company has a pipeline of innovative products.
View Top Employees from EndothelixWebsite | http://www.endothelix.com |
Revenue | $1 million |
Employees | 8 (7 on RocketReach) |
Founded | 2003 |
Address | 7676 Hillmont St Ste 290Z, Houston, Texas 77040, US |
Phone | (650) 263-7636 |
Fax | (650) 425-3383 |
Technologies |
JavaScript,
PHP,
Google Analytics
+20 more
(view full list)
|
Industry | Retail, Medical Equipment Manufacturing, Biotechnology, Monitoring Equipment, Science and Engineering, Surgical Devices, Developer Tools, Software, Health Care, Hedge Funds, Financial Services, Lending and Investments, Information Technology, Medical |
Web Rank | 4 Million |
Keywords | Crucumin |
Competitors | Bacchus Vascular, Grange HR Consulting, Modus Health, PneumaCare Ltd, Rubitection Inc. |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 334 Companies |
Looking for a particular Endothelix employee's phone or email?
The Endothelix annual revenue was $1 million in 2024.
7 people are employed at Endothelix.
Endothelix is based in Houston, Texas.
The NAICS codes for Endothelix are [33, 334].
The SIC codes for Endothelix are [38, 384].